States Poised to Move Forward in Lowering Drug Costs
Drug Prices
States Poised to Move Forward in Lowering Drug Costs
Prescription for Higher Prices: The Real Cost of the EPIC Act
Drug Prices
Prescription for Higher Prices: The Real Cost of the EPIC Act
Commercial Rates in Medicaid: State-Directed Payments Need Scrutiny
Medicaid
Commercial Rates in Medicaid: State-Directed Payments Need Scrutiny
New Research Brief Finds Billions in Savings for Seniors
Commercial Sector Prices
New Research Brief Finds Billions in Savings for Seniors
Why Site-Neutral Payments Matter, Cutting Through Confusion
Same Service, Same Price
Why Site-Neutral Payments Matter, Cutting Through Confusion
As Reconciliation Commences, Cutting Health Care Costs Shouldn’t Mean Cutting Coverage
Federal Tax Policy
As Reconciliation Commences, Cutting Health Care Costs Shouldn’t Mean Cutting Coverage
Op-Ed
Reducing Federal Health Spending by Cutting Unnecessary Costs, Not Coverage
Drug Prices
Reducing Federal Health Spending by Cutting Unnecessary Costs, Not Coverage
John Arnold’s Top Three Health Care Reforms
Commercial Sector Prices
John Arnold’s Top Three Health Care Reforms
Ask the Experts: The Shift to Population-based Payment Models for Clinicians
Provider Payment Incentives
Ask the Experts: The Shift to Population-based Payment Models for Clinicians
National Poll Shows Voters Want Action to Lower Health Care Prices
Commercial Sector Prices
National Poll Shows Voters Want Action to Lower Health Care Prices
Drug Costs and Their Impact on Care
Drug Prices
Drug Costs and Their Impact on Care
AV Proposals for Achieving Fiscally Responsible Tax Reform
Federal Tax Policy
AV Proposals for Achieving Fiscally Responsible Tax Reform
Commercial Sector Prices
Medicare Already Pays 2 – 4x More for the Same Care — and the Gap is Growing
Why You Should Beware Hospital Consolidation
Commercial Sector Prices
Why You Should Beware Hospital Consolidation
Op-Ed
Time for a Shift in How We Pay for Primary Care
Provider Payment Incentives
Time for a Shift in How We Pay for Primary Care
“Not a Fair and Open Market” John Arnold on Health Care Reform at Forbes 400 Philanthropy Summit
Drug Prices
“Not a Fair and Open Market” John Arnold on Health Care Reform at Forbes 400 Philanthropy Summit
Provider Payment Incentives
AV Responds to Annual Medicare Physician Fee Schedule Proposed Rule
Clinical Trials
AV Submits Letter in Support of Proposed Patent Trial and Appeal Board Rules
Clinical Trials
Real World Data and the Formulation of Real-World Evidence
How Do Patients and Providers Feel About Drug Costs in Medicare?
Drug Prices
How Do Patients and Providers Feel About Drug Costs in Medicare?
Provider Payment Incentives
Bolstering Primary Care Through Payment Reform
Provider Payment Incentives
Senate Finance Committee Moves Toward Addressing Medicare Physician Payment Reform
Medicare Sustainability
Enhancing Transparency in Medicare Advantage Data
California Takes Step Forward to Control Health Care Costs
Commercial Sector Prices
California Takes Step Forward to Control Health Care Costs
About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.
